Iselin Local Business

Iselin Local Business

Local business in Iselin, NJ

  • Yesterday | via AmericanBankingNews.com 

    Digirad (DRAD) & Echo Therapeutics (ECTE) Head t...

    Digirad and Echo Therapeutics are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, risk, profitability, dividends and valuation. Digirad has a beta of 2.21, suggesting that its share price is 121% more volatile than the S&P 500.

    Comment?

    Related Topix: Echo Therapeutics, Suwanee, GA, Gwinnett County, GA

  • Tuesday Jul 31 | via Daily Political 

    Financial Survey: Echo Therapeutics

    Echo Therapeutics and Digirad are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk and analyst recommendations. 56.0% of Digirad shares are owned by institutional investors.

    Comment?

    Related Topix: Echo Therapeutics, Iselin, NJ

  • Saturday Jul 28 | via PR.com 

    FDA Releases Biosimilar Action Plan - Hear More at T...

    SMi Group Reports: Following the FDA's release of a Biosimilar Action Plan, this year's Biosimilars USA conference promises to explore the developments in biosimilar drug development. Iselin, NJ, July 28, 2018 -- -- As the world of biosimilars gains more traction and promise, and the FDA announces the release of a long-awaited Biosimilar Action Plan, SMi's 5th Annual Biosimilars USA Conference, taking place in New Jersey, USA on the 14th and 15th November 2018, aims to give crucial updates to biosimilar experts and scientific pioneers across the world in this rapidly evolving industry.

    Comment?

    Related Topix: Iselin, NJ, Amgen

  • Wednesday Jul 25 | via Newsday 

    Retired founder of TSR Inc. and his wife sell stake ...

    The $5.1 million deal with Zeff Capital comes a year after the computer staffing business rejected Zeff's bid to acquire the entire company. The retired founder and former chief executive of TSR Inc. and his wife have agreed to sell a 41.8 percent stake in the staffing company worth $5.1 million to Zeff Capital LP and two partners Photo Credit: Steve Pfost The retired founder and former chief executive of TSR Inc. and his wife have agreed to sell a 41.8 percent stake in the staffing company worth $5.1 million to Zeff Capital LP and two partners, the company disclosed in a government filing Wednesday.

    Comment?

    Related Topix: TSR, IT Services, Human Resources, Software